Capitals

Armstrong won't fight USADA charges, will lose Tour titles

Armstrong won't fight USADA charges, will lose Tour titles

Lance Armstrong's statement released Thursday night

USADA to strip Armstrong of Tour titles, ban for life

AUSTIN, Texas (AP) -- Lance Armstrong said Thursday night he is finished fighting a barrage of drug charges from the U.S. Anti-Doping Agency, putting his unprecedented string of seven Tour de France titles at risk along with his legacy as one of the greatest cyclists in history.

The decision sets up a likely lifetime ban from the sport and the possibility that Armstrong will be stripped of his signature achievement -- the extraordinary run of Tour titles he won from 1999-2005.

Armstrong, who retired last year, declined to enter arbitration -- his last option -- because he said he was weary of fighting accusations that have dogged him for years. He has consistently pointed to the hundreds of drug tests that he has passed as proof of his innocence.

"There comes a point in every man's life when he has to say, "Enough is enough." For me, that time is now," Armstrong said in a statement sent to The Associated Press. He called the USADA investigation an "unconstitutional witch hunt."

"I have been dealing with claims that I cheated and had an unfair advantage in winning my seven Tours since 1999," he said. "The toll this has taken on my family and my work for our foundation and on me leads me to where I am today - finished with this nonsense."

USADA will almost certainly treat Armstrong's decision as an admission of guilt, and hang the label of drug cheat on an athlete who was a hero to thousands for overcoming life-threatening testicular cancer and for his foundation's support for cancer research.

The agency can impose a lifetime ban and recommend Armstrong be stripped of his titles. That would put the question in the hands of the International Cycling Union, which has disputed USADA's authority to pursue the investigation and Tour de France officials, who have had a prickly relationship with Armstrong over the years.

Armstrong insisted his decision is not an admission of drug use, but a refusal to enter an arbitration process he believes is improper and unfair to athletes facing charges.

"USADA cannot assert control of a professional international sport and attempt to strip my seven Tour de France titles," he said. "I know who won those seven Tours, my teammates know who won those seven Tours, and everyone I competed against knows who won those seven Tours."

USADA maintains that Armstrong has used banned substances as far back as 1996, including the blood-booster EPO and steroids as well as blood transfusions -- all to boost his performance.

The 40-year-old Armstrong walked away from the sport in 2011 without being charged following a two-year federal criminal investigation into many of the same accusations he faces from USADA. The federal probe was closed in February, but USADA announced in June it had evidence Armstrong used banned substances and methods -- and encouraged their use by teammates. The agency also said it had blood tests from 2009 and 2010 that were "fully consistent" with blood doping.

Included in USADA's evidence were emails written by Armstrong's former U.S. Postal Service teammate Floyd Landis, who was stripped of his 2006 Tour de France title after a positive drug test. Landis' emails to a USA Cycling official detailed allegations of a complex doping program on the team.

USADA also said it had 10 former Armstrong teammates ready to testify against him. Other than suggesting they include Landis and Tyler Hamilton, both of whom have admitted to doping offenses, the agency has refused to say who they are or specifically what they would say.

"There is zero physical evidence to support (the) outlandish and heinous claims. The only physical evidence here is the hundreds of (doping) controls I have passed with flying colors," Armstrong said.

Armstrong sued USADA in Austin, where he lives, in an attempt to block the case and was supported by the UCI, the sport's governing body. A judge threw out the case on Monday, siding with USADA despite questioning the agency's pursuit of Armstrong in his retirement.

"USADA's conduct raises serious questions about whether its real interest in charging Armstrong is to combat doping, or if it is acting according to less noble motives," such as politics or publicity, U.S. District Judge Sam Sparks wrote.

Now the ultra-competitive Armstrong has done something virtually unthinkable for him: He has quit before a fight is over.

"Today I turn the page. I will no longer address this issue, regardless of the circumstances. I will commit myself to the work I began before ever winning a single Tour de France title: serving people and families affected by cancer, especially those in underserved communities," Armstrong said.

Armstrong could have pressed his innocence in USADA's arbitration process, but the cyclist has said he believes most people have already made up their minds about whether he's a fraud or a persecuted hero.

It's a stunning move for an athlete who built his reputation on not only beating cancer, but forcing himself through grueling offseason workouts no one else could match, then crushing his rivals in the Alps and the Pyrenees.

Although he had already been crowned a world champion and won individual stages at the Tour de France, Armstrong was still relatively unknown in the U.S. until he won the epic race for the first time in 1999. It was the ultimate comeback tale: When diagnosed with cancer, doctors had given him less than a 50 percent chance of survival before surgery and brutal cycles of chemotherapy saved his life.

Armstrong's riveting victories, his work for cancer awareness and his gossip-page romances with rocker Sheryl Crow, fashion designer Tory Burch and actress Kate Hudson made him a figure who transcended sports.

His dominance of the Tour de France elevated the sport's popularity in America to unprecedented levels. His story and success helped sell millions of the "Livestrong" plastic yellow wrist bracelets, and enabled him to enlist lawmakers and global policymakers to promote cancer awareness and research. His Lance Armstrong Foundation has raised nearly 500 million since its founding in 1997.

Created in 2000, USADA is recognized by Congress as the official anti-doping agency for Olympic sports in the United States. Its investigators joined U.S. agents during the federal probe, and USADA chief executive Travis Tygart had dismissed Armstrong's lawsuit as an attempt at "concealing the truth." He said the agency is motivated by one goal -- exposing cheaters in sport.

Others close to Armstrong were caught up in the charges: Johan Bruyneel, the coach of Armstrong's teams, and three members of the medical staff and a consultant were also charged. Bruyneel is taking his case to arbitration, while two medical team staffers and consulting doctor Michele Ferrari didn't formally contest the charges and were issued lifetime ban by USADA. Ferrari later said he was innocent.

In a sport rife with cheaters, Armstrong has been under constant suspicion since the 1990s from those who refused to believe he was a clean rider winning cycling's premier event against a field of doped-up competition.

He had tense public disputes with USADA, the World Anti-Doping Agency, some former teammates and assistants and even Greg LeMond, the first American to win the Tour de France.

Through it all, Armstrong vigorously denied any and all hints, rumors and direct accusations he was cheating. He had the blazing personality, celebrity and personal wealth needed to fight back with legal and public relations battles to clear his name -- and he did, time after time.

Armstrong won his first Tour at a time when doping scandals had rocked the race. He was leading the race when a trace amount of a banned anti-inflammatory corticosteroid was found in his urine; cycling officials said he was authorized to use a small amount of a cream to treat saddle sores.

After Armstrong's second victory in 2000, French judicial officials investigated his Postal Service team for drug use. That investigation ended with no charges, but the allegations kept coming.

Armstrong was criticized for his relationship with Ferrari, who was banned by Italian authorities over doping charges in 2002. Former personal and team assistants accused Armstrong of having steroids in an apartment in Spain and disposing of syringes that were used for injections.

In 2004, a Dallas-based promotions company initially refused to pay him a 5 million bonus for winning his sixth Tour de France because it wanted to investigate allegations raised by media in Europe. Testimony in that case included former teammate Frankie Andreu and his wife, Betsy, saying Armstrong told doctors during his 1996 cancer treatments that he had taken a cornucopia of steroids and performance-enhancing drugs.

Two books published in Europe, "L.A. Confidential" and "L.A. Official," also raised doping allegations and, in 2005, French magazine L'Equipe reported that retested urine samples from the 1999 Tour showed EPO use.

Armstrong fought every accusation with denials and, in some cases, lawsuits against the European media outlets that reported them.

But he showed signs that he was tiring of the never-ending questions. Armstrong retired (for the first time) in 2005 and almost immediately considered a comeback before deciding to stay on the sidelines, in part, because he didn't want to keep answering doping questions.

"I'm sick of this," Armstrong said in 2005. "Sitting here today, dealing with all this stuff again, knowing if I were to go back, there's no way I could get a fair shake -- on the roadside, in doping control, or the labs."

But three years later, Armstrong was 36 and itching to ride again. He came back to finish third in the 2009 Tour de France.

Armstrong raced in the Tour again in 2010, under the cloud of the federal criminal investigation. Early last year, he quit the sport for good, but made a brief return as a triathlete until the USADA investigation shut him down.

During his sworn testimony in the dispute over the 5 million bonus, Armstrong said he wouldn't take performance enhancing drugs because he had too much to lose.

"(The) faith of all the cancer survivors around the world. Everything I do off the bike would go away, too," Armstrong said then. "And don't think for a second I don't understand that. It's not about money for me. Everything. It's also about the faith that people have put in me over the years. So all of that would be erased."

Quick Links

Caps GM Brian MacLellan addresses latest Andre Burakovsky trade rumors

usatsi_andre_burakovsky.jpg
USATSI

Caps GM Brian MacLellan addresses latest Andre Burakovsky trade rumors

Capitals forward Andre Burakovsky dodges trade rumors like Indiana Jones escaped giant rolling stones.

When Burakovsky made it through the Feb. 25 NHL trade deadline still with Washington it appeared he was here to stay a while longer. He even played better down the stretch. But that might not have been enough to save him. 

Multiple NHL sources said Wednesday that Burakovsky would likely be dealt at this weekend’s NHL Draft in Vancouver. There is no question he is drawing interest from teams around the league.  

“We'd like to keep him around, but obviously his name is out there a little bit, so we do talk to some teams about him,” Capitals general manager Brian MacLellan said in a conference call on Thursday. “But we're not going to move him unless we get something we're comfortable with back.”

MacLellan, as blunt a general manager as there is in the NHL, might be employing semantics there. The Capitals are trying to get what they can and won’t undercut their own leverage by saying Burakovsky is out the door.

Burakovsky has frustrated coaches and executives alike in Washington. He flashes great potential and has the pedigree to be a solid middle-six forward. But he’s been stuck on 12 goals three years in a row and can’t seem to find a consistent role. Last year he was a healthy scratch six times. 

Injuries played some role in that in previous years. But Burakovsky hasn’t taken advantage of his opportunities, either. Yet he has also come up with some incredible goals. Three times he’s scored in a Game 7 in the Stanley Cup playoffs. No one can forget his goals against Tampa Bay in the 2018 Eastern Conference Final that secured Washington’s trip to the Stanley Cup Final. He’s also entering his age-25 season and had 17 goals in his second season in the NHL. 

But with a $3.25 million qualifying offer due Monday and the salary cap possibly tighter than expected, Washington might not have a choice even if it has a last-second change of heart on trading Burakovsky. 

It’s not know exactly what kind of deal the Capitals are pursuing: A one-for-one deal with a player who has his own issues? A mix of draft picks and prospects who won’t contribute to a team in “win-now” mode? Washington could always pull back – as they did at the deadline. But without knowing what MacLellan feels he needs from a Burakovsky trade it’s hard to know what would give him another chance to stay.

MacLellan wouldn’t even commit to tendering Burakovsky that $3.25 million qualifying offer by Monday’s deadline. He said Washington will take a look at the salary cap once the NHL gets around to announcing it hopefully by Saturday at the draft. Then they’ll check back with the agents of all their RFAs – Jakub Vrana is safe - and decide how to proceed. 

But if they don’t qualify Burakovsky, the one other RFA they have the rights to who would draw interest around the league, he becomes an unrestricted free agent and can sign anywhere. Hard to see how that benefits the Capitals to lose an asset they claim to value for nothing. Time is running short.

“Andre had a frustrating year this year, but I think he finished it up well,” MacLellan said. “I think from the trade deadline on, I thought he had a good playoffs. We like the player. There's been some inconsistencies there, but when he's on his game, he's a good player.”

MORE CAPITALS NEWS

Quick Links

Uncertainty over NHL salary cap has Caps GM Brian MacLellan frustrated

maclellan-ap.jpg
Associated Press Images

Uncertainty over NHL salary cap has Caps GM Brian MacLellan frustrated

Capitals general manager Brian MacLellan had a number in his head. It is the most important one for any NHL executive heading into the offseason: $83 million. 

That was the expected salary cap for the 2019-20 season and – with some small margin for error – the amount MacLellan and his staff used to formulate their offseason plan. But it is June 20 and the number that was originally at $83 million could drop to as low as $81.5 million, according to Sportsnet’s Elliotte Friedman. 

Given that Washington has some carryover for bonuses and overages from last season worth about $1.150 million, it could be working with a cap number as low as $80.35 million. That is not ideal for a team where every dollar could spell the difference between upgrading its middle-six forwards or adding a veteran fourth-line player. 

The NHL is expected to come to an agreement with the NHL Players’ Association soon and let teams know the number by Saturday, the second day of the entry draft in Vancouver. That’s a few days later than normal, however, and forces GMs to make decisions during the draft regarding trades and picking prospects they otherwise might not.   

"It's frustrating. We've been projecting using that 83 (million dollars) number for the last part of the year,” MacLellan told reporters in a conference call on Thursday. “At some point, we switched back to the 82.5 because there was some rumblings there, and now it seems to be going back a little further. I know it seems like it's not a large amount of dollars, but it does impact teams that are right at the number as far as salary.”

On an $82 million cap, the Capitals have about $9.7 million in room according to the great web site CapFriendly.com. But they need to sign restricted free agent Jakub Vrana and add four other bottom-six forwards and a depth defenseman. That is an extremely tight fit and might rule out some free agent options MacLellan had interest in. 

The free-agent “interview” period begins Sunday when teams can talk to agents of pending free agents and gauge what their demands will be and if they are a fit when the market opens on July 1. 

That, in turn, effects negotiations with Vrana and any other RFAs (Andre Burakovsky, Chandler Stephenson, Christian Djoos) that Washington might want to bring back. Burakovsky is likely to be traded at the draft this weekend, according to multiple NHL sources with knowledge of Washington’s thinking. A further budget crunch would seem to seal his fate.  

MacLellan wouldn’t confirm that and even said “we like the player.” But Burakovsky is due a $3.25 million qualifying offer by Monday so the decision might have been made for them. If the cap is the worst-case scenario ($81.5 million) the Capitals are in a real bind. But they’d like to know for sure.   

“When you see it go down to maybe 81.5, I think there's a pause on our part,” MacLellan said. “We want to see the number before we move forward because it's going to affect our roster decisions even on the bottom end - on fourth line and what we have to do going forward because the margins are that slim for us."

MORE CAPITALS NEWS